Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 6Centocor

02 18Janssen-Cilag

03 1Natco Pharma

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

DCAT Week
Not Confirmed
arrow
arrow
DCAT Week
Not Confirmed

ERDAFITINIB

Brand Name : BALVERSA

Dosage Form : TABLET;ORAL

Dosage Strength : 3MG

Packaging :

Approval Date : 2019-04-12

Application Number : 212018

Regulatory Info : RX

Registration Country : USA

blank

02

DCAT Week
Not Confirmed
arrow
arrow
DCAT Week
Not Confirmed

ERDAFITINIB

Brand Name : BALVERSA

Dosage Form : TABLET;ORAL

Dosage Strength : 4MG

Packaging :

Approval Date : 2019-04-12

Application Number : 212018

Regulatory Info : RX

Registration Country : USA

blank

03

DCAT Week
Not Confirmed
arrow
arrow
DCAT Week
Not Confirmed

ERDAFITINIB

Brand Name : BALVERSA

Dosage Form : TABLET;ORAL

Dosage Strength : 5MG

Packaging :

Approval Date : 2019-04-12

Application Number : 212018

Regulatory Info : RX

Registration Country : USA

blank

04

DCAT Week
Not Confirmed
arrow
arrow
DCAT Week
Not Confirmed

Erdafitinib

Brand Name : Balversa

Dosage Form : Film Coated Tablet

Dosage Strength : 3mg

Packaging :

Approval Date : 14/01/2025

Application Number : 67660

Regulatory Info : Allowed

Registration Country : Switzerland

blank

05

DCAT Week
Not Confirmed
arrow
arrow
DCAT Week
Not Confirmed

Erdafitinib

Brand Name : Balversa

Dosage Form : Film Coated Tablet

Dosage Strength : 4mg

Packaging :

Approval Date : 14/01/2025

Application Number : 67660

Regulatory Info : Allowed

Registration Country : Switzerland

blank

06

DCAT Week
Not Confirmed
arrow
arrow
DCAT Week
Not Confirmed

Erdafitinib

Brand Name : Balversa

Dosage Form : Film Coated Tablet

Dosage Strength : 5mg

Packaging :

Approval Date : 14/01/2025

Application Number : 67660

Regulatory Info : Allowed

Registration Country : Switzerland

blank

07

DCAT Week
Not Confirmed
arrow
arrow
DCAT Week
Not Confirmed

Erdafitinib

Brand Name : Balversa

Dosage Form : Film Coated Tablet

Dosage Strength : 3mg

Packaging :

Approval Date :

Application Number :

Regulatory Info : Marketed

Registration Country : Norway

blank

08

DCAT Week
Not Confirmed
arrow
arrow
DCAT Week
Not Confirmed

Erdafitinib

Brand Name : Balversa

Dosage Form : Film Coated Tablet

Dosage Strength : 4mg

Packaging :

Approval Date :

Application Number :

Regulatory Info : Marketed

Registration Country : Norway

blank

09

DCAT Week
Not Confirmed
arrow
arrow
DCAT Week
Not Confirmed

Erdafitinib

Brand Name : Balversa

Dosage Form : Film Coated Tablet

Dosage Strength :

Packaging :

Approval Date :

Application Number :

Regulatory Info : Marketed

Registration Country : Norway

blank

10

DCAT Week
Not Confirmed
arrow
arrow
DCAT Week
Not Confirmed

Erdafitinib

Brand Name : Balversa

Dosage Form : Film-Coated Tablet

Dosage Strength : 3mg

Packaging :

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Estonia

blank

11

DCAT Week
Not Confirmed
arrow
arrow
DCAT Week
Not Confirmed

Erdafitinib

Brand Name : Balversa

Dosage Form : Film-Coated Tablet

Dosage Strength : 4mg

Packaging :

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Estonia

blank

12

DCAT Week
Not Confirmed
arrow
arrow
DCAT Week
Not Confirmed

Erdafitinib

Brand Name : Balversa

Dosage Form : Film-Coated Tablet

Dosage Strength : 5mg

Packaging :

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Estonia

blank

13

DCAT Week
Not Confirmed
arrow
arrow
DCAT Week
Not Confirmed

Erdafitinib

Brand Name : Balversa

Dosage Form : Film Coated Tablet

Dosage Strength : 3MG

Packaging :

Approval Date : 27-08-2024

Application Number : 1241841004

Regulatory Info : Authorized

Registration Country : Spain

blank

14

DCAT Week
Not Confirmed
arrow
arrow
DCAT Week
Not Confirmed

Erdafitinib

Brand Name : Balversa

Dosage Form : Film Coated Tablet

Dosage Strength : 4MG

Packaging :

Approval Date : 27-08-2024

Application Number : 1241841009

Regulatory Info : Authorized

Registration Country : Spain

blank

15

DCAT Week
Not Confirmed
arrow
arrow
DCAT Week
Not Confirmed

Erdafitinib

Brand Name : Balversa

Dosage Form : Film Coated Tablet

Dosage Strength : 5MG

Packaging :

Approval Date : 27-08-2024

Application Number : 1241841011

Regulatory Info : Authorized

Registration Country : Spain

blank

16

DCAT Week
Not Confirmed
arrow
arrow
DCAT Week
Not Confirmed

Erdafitinib

Brand Name : Balversa

Dosage Form : Film Coated Tablet

Dosage Strength : 3mg

Packaging :

Approval Date : 22-08-2024

Application Number : 28107045223

Regulatory Info : Prescription

Registration Country : Denmark

blank

17

DCAT Week
Not Confirmed
arrow
arrow
DCAT Week
Not Confirmed

Erdafitinib

Brand Name : Balversa

Dosage Form : Film Coated Tablet

Dosage Strength : 5mg

Packaging :

Approval Date : 22-08-2024

Application Number : 28107045423

Regulatory Info : Prescription

Registration Country : Denmark

blank

18

DCAT Week
Not Confirmed
arrow
arrow
DCAT Week
Not Confirmed

Erdafitinib

Brand Name : Balversa

Dosage Form : Film Coated Tablet

Dosage Strength :

Packaging :

Approval Date : 22-08-2024

Application Number : 28107045323

Regulatory Info : Prescription

Registration Country : Denmark

blank

19

DCAT Week
Not Confirmed
arrow
arrow
DCAT Week
Not Confirmed

Erdafitinib

Brand Name : Balversa

Dosage Form : Film Coated Tablet

Dosage Strength :

Packaging :

Approval Date : 22-08-2024

Application Number : 2.02E+13

Regulatory Info : Approved

Registration Country : Sweden

blank

20

DCAT Week
Not Confirmed
arrow
arrow
DCAT Week
Not Confirmed

ERDAFITINIB

Brand Name : ERDAFITINIB

Dosage Form : TABLET

Dosage Strength :

Packaging :

Approval Date :

Application Number : 218578

Regulatory Info :

Registration Country : USA

blank